Pharma Fraud
This archive displays posts tagged as relevant to pharmaceutical fraud. You may also be interested in our pages:
July 24, 2018
Attorney General Pam Bondi announced the arrest of a doctor, Armando Falcon, and two office managers, Claudia Centeno and Reveka Karagiann, in relation to charges for illegal sale of prescription drugs. Dr. Falcon owned and operated Pain Center of Cutler Bay in South Florida. Dr. Falcon allegedly met with patients for less than two minutes before writing prescriptions for oxycodone. The two office managers allegedly printed prescriptions for large quantities of oxycodone before Dr. Falcon arrived in the office to expedite the process of selling the drugs. FL AGJuly 20, 2018
Attorney General Barbara Underwood announced a six month jail sentence and $1.5 million in restitution payments for Arkady Goldin owner of Value Pharmacy, Inc. for defrauding the New York State Medicaid program. Mr. Goldin had pleaded guilty to second degree health care fraud in June for entering into a kickback arrangement with a former hospital employee to steer prescriptions to Value Pharmacy. Value then submitted false claims to Medicaid for medications it never dispensed to patients. NY AGHow Copayment Waivers can Give Rise to a Whistleblower Claim
Posted 06/8/18
What’s not to like about a doctor waiving a patient’s copayment, or a pharmaceutical company offering a prescription drug assistance program? Turns out there are plenty of reasons to be concerned about such activities. And, as a recently announced $24 million settlement with Pfizer illustrates, unlawful patient cost waivers can result in big liability for defendants.
Patient cost-sharing is a core principle...
May 31, 2018
Irina Minkovich and Yelena Babchinetskya, owners of Philadelphia-based I&L Express Pharmacy, entered into an integrity agreement and will pay $3.2 million to the federal government to resolve allegations that they violated the False Claims Act over a six-year period by billing Medicare for prescription drugs never dispensed to patients. USAO EDPAMay 29, 2018
Wal-Mart and Sam’s Club will collectively pay $825,000 to resolve federal and state False Claims Act allegations the company’s automatic prescription refills for Minnesota Medicaid patients violated Minnesota law and wasted taxpayer dollars on unnecessary and unused medications. USAO DMNMay 24, 2018
Pharmaceutical giant Pfizer agreed to pay $23.85 million and enter in to a corporate integrity agreement to resolve claims under the False Claims Act that it induced Medicare patients to use three Pfizer drugs, Sutent, Ilyta, and Tikosyn, by unlawfully covering patients copays in violation of the AKS; in doing so, Pfizer increased its profits and masked the effect of drug price increases. DOJPfizer Agrees to Pay $23.85 Million to Resolve False Claims Act Liability for Paying Kickbacks
Posted 05/24/18
The Department of Justice today announced that Pfizer agreed to pay $23.85 million to resolve allegations that it used a foundation as a conduit to pay the copays of Medicare patients taking three Pfizer drugs. Medicare Part B or D beneficiaries typically make a partial payment when obtaining prescription drugs in the form of a copay, coinsurance, or deductible. Under the Anti-Kickback Statute, pharmaceutical...
Ex-Manager and CEO Convicted in $9.7 Million Valeant Kickback Scheme
Posted 05/23/18
By the C|C Whistleblower Lawyer Team
Yesterday, a federal jury in Manhattan convicted Gary Tanner, a midlevel executive at Valeant Pharmaceuticals International, and Andrew Davenport, the CEO of Philidor Rx Services, of conspiring to bring about Valeant’s purchase of Philidor in exchange for a $9.7 million kickback.
The scheme allegedly netted Davenport $40 million, and he kicked back a portion of it to...